Latest Headlines

  1. MKS Announces Ophir® BeamSquared™ 2.0, Laser Beam Propagation System for Continuous Use Applications

    MKS Instruments, Inc., a global provider of technologies that enable advanced processes and improve productivity, announces Ophir® BeamSquared™ 2.0, the newest version of the company's M2 laser beam propagation system designed to help users optimize laser performance. A robust, portable device, BeamSquared automatically measures the propagation characteristics of CW and pulsed lasers quickly, in less than one minute.

  2. MKS Announces Ophir® Laser Power Sensors With Very High Damage Threshold, Very Low Reflection

    Munich, Germany - MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, has announced a new line of high damage threshold laser power/energy sensors designed for CW lasers with high power densities, as well as long as for pulse lasers. The Ophir® 1000W-LP2-34, L1500W-LP2-50, 5000W-LP2-50, and FL600A-LP2-65 feature a new LP2 coating that provides the highest damage threshold in the industry, 10kW/cm2 at 1kW power.  

  3. Medtronic, Aetna Ink Agreement That Ties Insulin Pump Payment To Patient Outcomes

    Medtronic plc, the global leader in medical technology, recently announced a new outcomes-based agreement with Aetna for type 1 and type 2 diabetes patients currently on multiple daily insulin injections for their diabetes management.

  4. Philips Releases Intellivue X3 Monitor In Europe

    Royal Philips (NYSE: PHG AEX: PHIA), a global health technology company, today announced the release of the IntelliVue X3 in Europe.

  5. Philips To Acquire Brain Monitoring Company Electrical Geodesics, Inc.

    Royal Philips , a global leader in health technology, recently announced an agreement to acquire Electrical Geodesics, Inc. (EGI), a US-based medical device company that designs, develops and commercializes a range of non-invasive technologies used to monitor and interpret brain activity. EGI’s portfolio of EEG hardware, software and acquisition sensors will complement Philips’ existing portfolio of imaging technologies (e.g. MRI and PET-CT) and advanced informatics (e.g. IntelliSpace Portal) for neurological applications.

  6. FDA Grants Merit Medical’s Embosphere Microspheres de novo Classification For Prostatic Artery Embolization)

    Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endoscopy, today announced that it has received 513(f)(2) (de novo) classification from the FDA to expand indication for Merit’s Embosphere® Microspheres.


  7. FDA Clears First RF Ablation Treatment For Osteoarthritis Knee Pain

    The U.S. Food and Drug Administration (FDA) has approved the first and only radio frequency (RF) treatment to be cleared specifically to alleviate chronic knee pain due to osteoarthritis.

  8. MKS' Ophir® Business Unit Announces Large Array Laser Beam Profiling Camera With Quick And Easy USB Interfacing

    MKS Instruments, Inc., a global provider of technologies that enable advanced processes and improve productivity, has announced the Ophir® Pyrocam™ IV USB, a laser beam profiling camera that allows users to see their laser beam for dynamic alignment and proper operation. The camera features a 320 x 320 pixel pyroelectric array that can profile beams up to 1 inch (25 mm) without the need for reduction optics. It also includes a new USB 3.0 interface that provides a quick and easy connection to PCs for beam analysis, 2D and 3D beam display, as well as trending, data logging, and storage.

  9. Exactech’s Computer-Assisted Shoulder Arthroplasty Tech Gains FDA Clearance

    Exactech, Inc., a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced recently it has received clearance from the U.S. Food and Drug Administration to market the ExactechGPS Shoulder Application

  10. FDA Grants HUD Designation To Novocure’s Tumor Treating Fields (TTFields) Delivery System

    Novocure announced recently that United States Food and Drug Administration (FDA) has designated it’s Tumor Treating Fields (TTFields) delivery system as a Humanitarian Use Device (HUD) for the treatment of pleural mesothelioma.